Fifth Third Bancorp
TARO

Fifth Third Bancorp’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Fifth Third Bancorp’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-30
Closed -$3K – 2378
2019
Q2 		$3K Buy
+30
New +$2.97K ﹤0.01% 2104
2014
Q2 		– Sell
-126
Closed -$14K – 2472
2014
Q1 		$14K Hold
126
– – ﹤0.01% 1908
2013
Q4 		$12K Hold
126
– – ﹤0.01% 1811
2013
Q3 		$10K Hold
126
– – ﹤0.01% 1878
2013
Q2 		$7K Buy
+126
New +$7.45K ﹤0.01% 1874

Other funds holding TARO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CAM
Claret Asset Management Montreal, Quebec, Canada $837M AUM 25.51% 1-Year Est. Return

Fifth Third Bancorp's TARO Position: Q3 2019 in Review

Fifth Third Bancorp sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2019, closing a stake of 30 shares — an estimated $3K sold.

Fifth Third Bancorp first reported a position in TARO in Q2 2013 and held it in 5 quarters. The position peaked at $14K in Q1 2014. 101 funds tracked by Wall St. Rank hold TARO as of Q3 2019.

  • Fifth Third Bancorp reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2019 after selling out during the quarter.
  • Fifth Third Bancorp sold 30 Taro Pharmaceutical Industries Ltd. shares in Q3 2019, an estimated $3K.
  • Fifth Third Bancorp first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2013 and held it in 5 quarters.
  • Fifth Third Bancorp's Taro Pharmaceutical Industries Ltd. position peaked at $14K in Q1 2014.
  • 101 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2019.

Based on Fifth Third Bancorp's 13F filing for Q3 2019, filed 14 Nov 2019.